SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-008888
Filing Date
2023-03-24
Accepted
2023-03-24 16:30:18
Documents
13
Period of Report
2023-03-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42780
2 ex3-1.htm EX-3.1 32284
  Complete submission text file 0001493152-23-008888.txt   257205

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE imnn-20230324.xsd EX-101.SCH 3221
4 XBRL LABEL FILE imnn-20230324_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE imnn-20230324_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3720
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 23760224
SIC: 2834 Pharmaceutical Preparations